1. Home
  2. APYX

as 05-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Medical/Dental Instruments

Nasdaq

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Founded: N/A Country:
United States
United States
Employees: N/A City: CLEARWATER
Market Cap: 48.8M IPO Year: 1987
Target Price: $6.17 AVG Volume (30 days): 158.7K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $1.21 - $7.97 Next Earning Date: 05-09-2024
Revenue: $50,451,000 Revenue Growth: 14.25%
Revenue Growth (this year): -2.7% Revenue Growth (next year): 9.19%

Share on Social Networks:

Stock Insider Trading Activity of Apyx Medical Corporation (APYX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
HILL MATTHEW C APYX Chief Financial Officer Dec 12 '23 Buy $2.19 2,500 $5,475.00 2,500 SEC Form 4
Goodwin Charles D. II APYX Chief Executive Officer Nov 14 '23 Buy $1.57 50,000 $78,500.00 90,000 SEC Form 4